nodes	percent_of_prediction	percent_of_DWPC	metapath
Lacosamide—Affect lability—Methylprednisolone—psoriatic arthritis	0.00504	0.00504	CcSEcCtD
Lacosamide—Psychotic disorder—Methylprednisolone—psoriatic arthritis	0.005	0.005	CcSEcCtD
Lacosamide—Dysarthria—Methotrexate—psoriatic arthritis	0.00493	0.00493	CcSEcCtD
Lacosamide—Irritability—Methylprednisolone—psoriatic arthritis	0.00488	0.00488	CcSEcCtD
Lacosamide—Mood swings—Triamcinolone—psoriatic arthritis	0.00486	0.00486	CcSEcCtD
Lacosamide—Mood swings—Methylprednisolone—psoriatic arthritis	0.00485	0.00485	CcSEcCtD
Lacosamide—Euphoric mood—Prednisone—psoriatic arthritis	0.0048	0.0048	CcSEcCtD
Lacosamide—Osteoarthritis—Betamethasone—psoriatic arthritis	0.00465	0.00465	CcSEcCtD
Lacosamide—Osteoarthritis—Dexamethasone—psoriatic arthritis	0.00465	0.00465	CcSEcCtD
Lacosamide—Affect lability—Betamethasone—psoriatic arthritis	0.00458	0.00458	CcSEcCtD
Lacosamide—Affect lability—Dexamethasone—psoriatic arthritis	0.00458	0.00458	CcSEcCtD
Lacosamide—Psychotic disorder—Betamethasone—psoriatic arthritis	0.00454	0.00454	CcSEcCtD
Lacosamide—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.00454	0.00454	CcSEcCtD
Lacosamide—Irritability—Betamethasone—psoriatic arthritis	0.00444	0.00444	CcSEcCtD
Lacosamide—Irritability—Dexamethasone—psoriatic arthritis	0.00444	0.00444	CcSEcCtD
Lacosamide—Mood swings—Betamethasone—psoriatic arthritis	0.00441	0.00441	CcSEcCtD
Lacosamide—Mood swings—Dexamethasone—psoriatic arthritis	0.00441	0.00441	CcSEcCtD
Lacosamide—Osteoarthritis—Prednisone—psoriatic arthritis	0.00405	0.00405	CcSEcCtD
Lacosamide—Affect lability—Prednisone—psoriatic arthritis	0.00399	0.00399	CcSEcCtD
Lacosamide—Psychotic disorder—Prednisone—psoriatic arthritis	0.00396	0.00396	CcSEcCtD
Lacosamide—Bradycardia—Prednisolone—psoriatic arthritis	0.00393	0.00393	CcSEcCtD
Lacosamide—Irritability—Prednisone—psoriatic arthritis	0.00387	0.00387	CcSEcCtD
Lacosamide—Mood swings—Prednisone—psoriatic arthritis	0.00384	0.00384	CcSEcCtD
Lacosamide—Bradycardia—Triamcinolone—psoriatic arthritis	0.00361	0.00361	CcSEcCtD
Lacosamide—Bradycardia—Methylprednisolone—psoriatic arthritis	0.0036	0.0036	CcSEcCtD
Lacosamide—Hallucination—Methylprednisolone—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Lacosamide—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00348	0.00348	CcSEcCtD
Lacosamide—Osteoarthritis—Methotrexate—psoriatic arthritis	0.00339	0.00339	CcSEcCtD
Lacosamide—Erythema—Prednisolone—psoriatic arthritis	0.00336	0.00336	CcSEcCtD
Lacosamide—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00331	0.00331	CcSEcCtD
Lacosamide—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00328	0.00328	CcSEcCtD
Lacosamide—Bradycardia—Betamethasone—psoriatic arthritis	0.00328	0.00328	CcSEcCtD
Lacosamide—Bradycardia—Dexamethasone—psoriatic arthritis	0.00328	0.00328	CcSEcCtD
Lacosamide—Neutropenia—Prednisone—psoriatic arthritis	0.00327	0.00327	CcSEcCtD
Lacosamide—Irritability—Methotrexate—psoriatic arthritis	0.00323	0.00323	CcSEcCtD
Lacosamide—Mood swings—Methotrexate—psoriatic arthritis	0.00321	0.00321	CcSEcCtD
Lacosamide—Hallucination—Dexamethasone—psoriatic arthritis	0.0032	0.0032	CcSEcCtD
Lacosamide—Hallucination—Betamethasone—psoriatic arthritis	0.0032	0.0032	CcSEcCtD
Lacosamide—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.0032	0.0032	CcSEcCtD
Lacosamide—Ataxia—Methotrexate—psoriatic arthritis	0.00318	0.00318	CcSEcCtD
Lacosamide—Vision blurred—Prednisolone—psoriatic arthritis	0.00316	0.00316	CcSEcCtD
Lacosamide—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.00313	0.00313	CcSEcCtD
Lacosamide—Depression—Prednisone—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Lacosamide—Mental disorder—Methylprednisolone—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Lacosamide—Erythema—Triamcinolone—psoriatic arthritis	0.00309	0.00309	CcSEcCtD
Lacosamide—Erythema—Methylprednisolone—psoriatic arthritis	0.00308	0.00308	CcSEcCtD
Lacosamide—Angioedema—Prednisolone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.00305	0.00305	CcSEcCtD
Lacosamide—Vertigo—Prednisolone—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Lacosamide—Syncope—Prednisolone—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Lacosamide—Eye disorder—Dexamethasone—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Lacosamide—Eye disorder—Betamethasone—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Lacosamide—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Lacosamide—Eosinophilia—Methotrexate—psoriatic arthritis	0.0029	0.0029	CcSEcCtD
Lacosamide—Bradycardia—Prednisone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Lacosamide—Discomfort—Prednisolone—psoriatic arthritis	0.00282	0.00282	CcSEcCtD
Lacosamide—Angioedema—Triamcinolone—psoriatic arthritis	0.00282	0.00282	CcSEcCtD
Lacosamide—Angioedema—Methylprednisolone—psoriatic arthritis	0.00282	0.00282	CcSEcCtD
Lacosamide—Erythema—Betamethasone—psoriatic arthritis	0.0028	0.0028	CcSEcCtD
Lacosamide—Erythema—Dexamethasone—psoriatic arthritis	0.0028	0.0028	CcSEcCtD
Lacosamide—Hallucination—Prednisone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Lacosamide—Vertigo—Triamcinolone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Lacosamide—Syncope—Triamcinolone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Lacosamide—Vertigo—Methylprednisolone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Lacosamide—Syncope—Methylprednisolone—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Lacosamide—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00275	0.00275	CcSEcCtD
Lacosamide—Neutropenia—Methotrexate—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Lacosamide—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Lacosamide—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Lacosamide—Shock—Prednisolone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Lacosamide—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Lacosamide—Eye disorder—Prednisone—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Lacosamide—Depression—Methotrexate—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Lacosamide—Discomfort—Triamcinolone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Lacosamide—Discomfort—Methylprednisolone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Lacosamide—Dry mouth—Triamcinolone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Lacosamide—Angioedema—Betamethasone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Lacosamide—Angioedema—Dexamethasone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Lacosamide—Confusional state—Methylprednisolone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Lacosamide—Immune system disorder—Prednisone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Lacosamide—Vertigo—Betamethasone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Lacosamide—Vertigo—Dexamethasone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Lacosamide—Syncope—Betamethasone—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Lacosamide—Syncope—Dexamethasone—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Lacosamide—Shock—Triamcinolone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Lacosamide—Insomnia—Prednisolone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Lacosamide—Shock—Methylprednisolone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Lacosamide—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Lacosamide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Lacosamide—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Lacosamide—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Lacosamide—Paraesthesia—Prednisolone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Lacosamide—Mental disorder—Prednisone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Lacosamide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Lacosamide—Erythema—Prednisone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Lacosamide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Lacosamide—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Lacosamide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Lacosamide—Discomfort—Dexamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Lacosamide—Discomfort—Betamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Lacosamide—Hepatitis—Methotrexate—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Lacosamide—Vision blurred—Prednisone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Lacosamide—Insomnia—Triamcinolone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Lacosamide—Insomnia—Methylprednisolone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Lacosamide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Lacosamide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Lacosamide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Lacosamide—Anaemia—Prednisone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Lacosamide—Shock—Dexamethasone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Lacosamide—Shock—Betamethasone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Lacosamide—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Lacosamide—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Lacosamide—Agitation—Prednisone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Lacosamide—Angioedema—Prednisone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Lacosamide—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Lacosamide—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Lacosamide—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Lacosamide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Lacosamide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Lacosamide—Vertigo—Prednisone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Lacosamide—Eye disorder—Methotrexate—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Lacosamide—Syncope—Prednisone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Lacosamide—Tinnitus—Methotrexate—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Lacosamide—Urticaria—Prednisolone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Lacosamide—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Lacosamide—Fatigue—Triamcinolone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Lacosamide—Fatigue—Methylprednisolone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Lacosamide—Loss of consciousness—Prednisone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Lacosamide—Immune system disorder—Methotrexate—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Lacosamide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Lacosamide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Lacosamide—Insomnia—Dexamethasone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Lacosamide—Insomnia—Betamethasone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Lacosamide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Lacosamide—Paraesthesia—Betamethasone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Lacosamide—Discomfort—Prednisone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Lacosamide—Mental disorder—Methotrexate—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Lacosamide—Erythema—Methotrexate—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Lacosamide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Lacosamide—Dyspepsia—Betamethasone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Lacosamide—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Lacosamide—Urticaria—Triamcinolone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Lacosamide—Urticaria—Methylprednisolone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Lacosamide—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Lacosamide—Fatigue—Betamethasone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Lacosamide—Fatigue—Dexamethasone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Lacosamide—Shock—Prednisone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Lacosamide—Nervous system disorder—Prednisone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Lacosamide—Skin disorder—Prednisone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Lacosamide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Lacosamide—Vision blurred—Methotrexate—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Lacosamide—Anaemia—Methotrexate—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Lacosamide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Lacosamide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Lacosamide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Lacosamide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Lacosamide—Vertigo—Methotrexate—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Lacosamide—Urticaria—Dexamethasone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Lacosamide—Urticaria—Betamethasone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Lacosamide—Dizziness—Prednisolone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Lacosamide—Asthenia—Triamcinolone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Lacosamide—Body temperature increased—Betamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Lacosamide—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Lacosamide—Asthenia—Methylprednisolone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Lacosamide—Insomnia—Prednisone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Lacosamide—Paraesthesia—Prednisone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Lacosamide—Pruritus—Triamcinolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Lacosamide—Pruritus—Methylprednisolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Lacosamide—Dyspepsia—Prednisone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Lacosamide—Chest pain—Methotrexate—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Lacosamide—Rash—Prednisolone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Lacosamide—Dermatitis—Prednisolone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Lacosamide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Lacosamide—Fatigue—Prednisone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Lacosamide—Headache—Prednisolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Lacosamide—Discomfort—Methotrexate—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Lacosamide—Constipation—Prednisone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Lacosamide—Confusional state—Methotrexate—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Lacosamide—Dizziness—Triamcinolone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Lacosamide—Dizziness—Methylprednisolone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Lacosamide—Feeling abnormal—Prednisone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Lacosamide—Asthenia—Dexamethasone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Lacosamide—Asthenia—Betamethasone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Lacosamide—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Lacosamide—Nausea—Prednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Lacosamide—Pruritus—Dexamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Lacosamide—Pruritus—Betamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Lacosamide—Skin disorder—Methotrexate—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Lacosamide—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Lacosamide—Vomiting—Triamcinolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Lacosamide—Vomiting—Methylprednisolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Lacosamide—Rash—Triamcinolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Lacosamide—Dermatitis—Triamcinolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Lacosamide—Rash—Methylprednisolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Lacosamide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Lacosamide—Urticaria—Prednisone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Lacosamide—Headache—Triamcinolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Lacosamide—Headache—Methylprednisolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Lacosamide—Body temperature increased—Prednisone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Lacosamide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Lacosamide—Diarrhoea—Betamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Lacosamide—Dizziness—Betamethasone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Lacosamide—Dizziness—Dexamethasone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Lacosamide—Insomnia—Methotrexate—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Lacosamide—Nausea—Triamcinolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Lacosamide—Paraesthesia—Methotrexate—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Lacosamide—Nausea—Methylprednisolone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Lacosamide—Somnolence—Methotrexate—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Lacosamide—Hypersensitivity—Prednisone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Lacosamide—Dyspepsia—Methotrexate—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Lacosamide—Vomiting—Betamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Lacosamide—Vomiting—Dexamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Lacosamide—Rash—Betamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Lacosamide—Rash—Dexamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Lacosamide—Dermatitis—Dexamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Lacosamide—Dermatitis—Betamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Lacosamide—Fatigue—Methotrexate—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Lacosamide—Headache—Dexamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Lacosamide—Headache—Betamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Lacosamide—Asthenia—Prednisone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Lacosamide—Pruritus—Prednisone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Lacosamide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Lacosamide—Diarrhoea—Prednisone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Lacosamide—Nausea—Betamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Lacosamide—Nausea—Dexamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Lacosamide—Urticaria—Methotrexate—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Lacosamide—Dizziness—Prednisone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Lacosamide—Body temperature increased—Methotrexate—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Lacosamide—Vomiting—Prednisone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Lacosamide—Rash—Prednisone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Lacosamide—Dermatitis—Prednisone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Lacosamide—Headache—Prednisone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Lacosamide—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Lacosamide—Asthenia—Methotrexate—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Lacosamide—Nausea—Prednisone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Lacosamide—Pruritus—Methotrexate—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Lacosamide—Diarrhoea—Methotrexate—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Lacosamide—Dizziness—Methotrexate—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Lacosamide—Vomiting—Methotrexate—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Lacosamide—Rash—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Lacosamide—Dermatitis—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Lacosamide—Headache—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Lacosamide—Nausea—Methotrexate—psoriatic arthritis	0.000989	0.000989	CcSEcCtD
